- Home
- EMA vs ALGN Comparison
EMA vs ALGN Comparison
Compare EMA & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EMA
- ALGN
- Stock Information
- Founded
- EMA 1998
- ALGN 1997
- Country
- EMA Canada
- ALGN United States
- Employees
- EMA N/A
- ALGN N/A
- Industry
- EMA Electric Utilities: Central
- ALGN Industrial Specialties
- Sector
- EMA Utilities
- ALGN Health Care
- Exchange
- EMA Nasdaq
- ALGN Nasdaq
- Market Cap
- EMA 13.6B
- ALGN 12.5B
- IPO Year
- EMA N/A
- ALGN N/A
- Fundamental
- Price
- EMA $46.81
- ALGN $139.12
- Analyst Decision
- EMA Hold
- ALGN Buy
- Analyst Count
- EMA 1
- ALGN 13
- Target Price
- EMA $68.00
- ALGN $216.25
- AVG Volume (30 Days)
- EMA 159.9K
- ALGN 1.4M
- Earning Date
- EMA 08-08-2025
- ALGN 10-22-2025
- Dividend Yield
- EMA 4.42%
- ALGN N/A
- EPS Growth
- EMA 15.04
- ALGN 0.42
- EPS
- EMA 2.18
- ALGN 5.92
- Revenue
- EMA $6,033,610,485.00
- ALGN $3,964,802,000.00
- Revenue This Year
- EMA $25.82
- ALGN $2.03
- Revenue Next Year
- EMA N/A
- ALGN $3.31
- P/E Ratio
- EMA $21.84
- ALGN $23.50
- Revenue Growth
- EMA 12.01
- ALGN 0.56
- 52 Week Low
- EMA $43.90
- ALGN $127.70
- 52 Week High
- EMA $49.01
- ALGN $262.87
- Technical
- Relative Strength Index (RSI)
- EMA 44.47
- ALGN 40.99
- Support Level
- EMA $47.08
- ALGN $131.00
- Resistance Level
- EMA $47.56
- ALGN $143.28
- Average True Range (ATR)
- EMA 0.53
- ALGN 4.41
- MACD
- EMA -0.17
- ALGN 1.00
- Stochastic Oscillator
- EMA 10.23
- ALGN 42.25
About EMA Emera Incorporated Common Shares
Emera is a geographically diverse energy and services company investing in electricity generation, transmission, and distribution as well as gas transmission and utility energy services. Emera has operations throughout North America and the Caribbean countries.
About ALGN Align Technology Inc.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.